AngioDynamics (ANGO) Reports In-Line Q2 EPS, Miss on Revenues; Lowers FY18 Revenue Guidance Below Consensus

AngioDynamics (NASDAQ: ANGO) reported Q2 EPS of $0.16, in-line with the analyst estimate of $0.16. Revenue for the quarter came in at $86.7 million versus the consensus estimate of $88.42 million.

GUIDANCE:

AngioDynamics sees FY2018 EPS of $0.64-$0.68, versus the consensus of $0.66. AngioDynamics sees FY2018 revenue of $345-350 million, versus the consensus of $353.33 million.

For earnings history and earnings-related data on AngioDynamics (ANGO) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Cematrix wins $8.8M in new contracts, bringing YTD total to $43.2M
• Goldman Sachs Upgrades SK Innovation Co Ltd (096770:KS) to Neutral